Region: Global
Category: Diseases & Conditions

Global Diseases & Conditions

(10,590 reports matching your criteria)
  • Antimicrobial Textiles

    ... CAGR of 5.1% over the analysis period 2024-2030. Synthetic Organic Compounds, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$12.0 Billion by the end of the ... Read More

  • Autoimmune Disease Diagnosis

    ... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More

  • Automotive Fabrics

    ... CAGR of 3.0% over the analysis period 2024-2030. Floor Covering Application, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$10.8 Billion by the end of the ... Read More

  • Automotive Hydraulics System

    ... at a CAGR of 3.2% over the analysis period 2024-2030. Brake Application, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$20.1 Billion by the end of ... Read More

  • Automotive Washer Pumps

    ... at a CAGR of 3.2% over the analysis period 2024-2030. Mono Pumps, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$1.0 Billion by the end of ... Read More

  • Baking Ingredients

    ... CAGR of 4.8% over the analysis period 2024-2030. Baking Powder & Mixes, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$9.1 Billion by the end of ... Read More

  • Bouillon

    ... 4.9% over the analysis period 2024-2030. Meat Bouillon, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$7.1 Billion by the end of the analysis period. Growth ... Read More

  • Brewing Enzymes

    ... CAGR of 5.7% over the analysis period 2024-2030. Amylase, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$271.7 Million by the end of the analysis period. ... Read More

  • Cancer Diagnostics

    ... CAGR of 5.8% over the analysis period 2024-2030. Imaging, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$95.3 Billion by the end of the analysis period. ... Read More

  • Anticoagulants

    ... 9.2% over the analysis period 2024-2030. NOACs, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis period. Growth in ... Read More

  • Artificial Pancreas Device Systems

    ... 2030, growing at a CAGR of 18.8% over the analysis period 2024-2030. Threshold Suspended Device Systems, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$1.2 Billion ... Read More

  • Automotive Camshaft

    ... CAGR of 4.4% over the analysis period 2024-2030. Forged Camshaft, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$2.4 Billion by the end of the analysis ... Read More

  • Bioactive Materials

    ... CAGR of 9.0% over the analysis period 2024-2030. Glass Material, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$3.2 Billion by the end of the analysis ... Read More

  • Blood Pressure Transducers

    ... at a CAGR of 5.7% over the analysis period 2024-2030. Disposable Transducers, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$512.1 Million by the end of ... Read More

  • Burn Care

    ... CAGR of 3.9% over the analysis period 2024-2030. Advanced Burn Care, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.5 Billion by the end of the ... Read More

  • Cable Modem Termination System (CMTS) and Converged Cable Access Platform (CCAP)

    ... at US$7.1 Billion in the year 2024, is expected to reach US$12.1 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. CCAP, one of the segments analyzed in the report, ... Read More

  • Ceramic Textiles

    ... CAGR of 8.3% over the analysis period 2024-2030. RCF Fiber, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$160.7 Million by the end of the analysis ... Read More

  • Cervical Pillows

    ... CAGR of 5.4% over the analysis period 2024-2030. Standard Pillows, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.8 Billion by the end of the analysis ... Read More

  • Cold Pressed Juices

    ... at a CAGR of 5.6% over the analysis period 2024-2030. Organic Cold Pressed Juices, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$2.3 Billion by the ... Read More

  • Complex-Oxide Nanomaterials

    ... CAGR of 11.9% over the analysis period 2024-2030. Lithium Titanate, one of the segments analyzed in the report, is expected to record a 12.3% CAGR and reach US$1.8 Billion by the end of the analysis ... Read More

  • GMO Testing

    ... CAGR of 7.0% over the analysis period 2024-2030. Stacked Trait Testing, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$2.6 Billion by the end of the ... Read More

  • Healthcare Mobility Solutions

    ... at a CAGR of 18.9% over the analysis period 2024-2030. Mobile Devices, one of the segments analyzed in the report, is expected to record a 17.6% CAGR and reach US$120.5 Billion by the end of ... Read More

  • Hemophilia Drugs

    ... CAGR of 5.5% over the analysis period 2024-2030. Hemophilia A Drugs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$21.3 Billion by the end of the ... Read More

  • Herpes Marker Testing

    ... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More

  • Photography Equipment

    ... CAGR of -9.2% over the analysis period 2024-2030. Cameras, one of the segments analyzed in the report, is expected to record a -10.4% CAGR and reach US$2.1 Billion by the end of the analysis period. ... Read More

Cookie Settings